Deciphera Pharmaceuticals, Inc. (DCPH) SEC filings
DCPH SEC filings moved a median of -0.16% by the close. DCPH SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the DCPH overview →
19 measured DCPH SEC filing events.
Where these DCPH SEC filings landedvs 13 measured DCPH SEC filing reactions
| Middle 50% of DCPH SEC filing reactions | -1.73% to +3.10% |
|---|---|
| Median reaction (to close) | -0.16% |
| Measured reactions | 13 |
Point-in-time · zero look-ahead
Half of the 13 DCPH SEC filing events with a measured close landed between -1.73% and +3.10%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Deciphera Pharmaceutical | SEC filing · Form 15-12G | — | — | |
| Form EFFECT Deciphera Pharmaceutical | SEC filing · Form EFFECT | — | — | |
| Form 8-K Deciphera Pharmaceutical For: Jun 11 | SEC filing · Form 8-K | — | — | |
| Form POS AM Deciphera Pharmaceutical | SEC filing · Form POS | — | — | |
| Form POSASR Deciphera Pharmaceutical | SEC filing · Form POSASR | — | — | |
| Form S-8 POS Deciphera Pharmaceutical | SEC filing · Form S-8 | — | — | |
| Form 10-Q Deciphera Pharmaceutical For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.16% | |
| Form 8-K Deciphera Pharmaceutical For: Apr 29 | SEC filing · Form 8-K | +0.12% | +0.32% | |
| Form ARS Deciphera Pharmaceutical For: Dec 31 | SEC filing · Form ARS | +0.77% | +3.10% | |
| Form DEF 14A Deciphera Pharmaceutical For: Jun 20 | SEC filing · Form DEF | -0.69% | -1.73% | |
| Form DEFA14A Deciphera Pharmaceutical | SEC filing · Form DEFA14A | +0.77% | +3.10% | |
| Form PRER14A Deciphera Pharmaceutical | SEC filing · Form PRER14A | +0.00% | -1.42% | |
| Form PRE 14A Deciphera Pharmaceutical For: Jun 20 | SEC filing · Form PRE | -0.76% | -1.83% | |
| Form 10-K Deciphera Pharmaceutical For: Dec 31 | SEC filing · Form 10-K | -1.34% | -5.97% | |
| Form S-8 Deciphera Pharmaceutical | SEC filing · Form S-8 | -1.34% | -5.97% | |
| Form 8-K Deciphera Pharmaceutical For: Feb 06 | SEC filing · Form 8-K | -4.36% | -0.60% | |
| Form 8-K Deciphera Pharmaceutical For: Jan 08 | SEC filing · Form 8-K | -1.43% | +1.68% | |
| Form 10-Q Deciphera Pharmaceutical For: Sep 30 | SEC filing · Form 10-Q | -1.88% | +4.56% | |
| Form 8-K Deciphera Pharmaceutical For: Oct 30 | SEC filing · Form 8-K | -1.88% | +4.56% |
Keep exploring
More DCPH: earnings → · analyst actions → · DCPH overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Champions Oncology, Inc. (CSBR) | 130 | +0.20% | 53% |
| INNATE PHARMA (IPHYF) | 130 | 0.00% | 0% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 129 | -0.18% | 44% |
| Medicenna Therapeutics Corp (MDNA_TSE) | 127 | 0.00% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.